Kloser P, Passanante M, Mayberry B, Gill C, Cowan J; International Conference on AIDS.
Int Conf AIDS. 1994 Aug 7-12; 10: 312 (abstract no. PC0176).
UMDNJ.
OBJECTIVE: To compare the incidence and effect of viral hepatitis between ever intravenous (IVU) drug use and never intravenous drug use among HIV-infected women in NWAC (Newark Women's AIDS Clinic). METHOD: A random retrospective chart review of 146 HIV-infected women at comparable disease stages with and without IVU history. RESULTS: TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSION: HBV or HCV are present in close to 40% of NWAC patients and is a problem in our practice. HCV infection is equally likely in IVU and non-IVU while HBV alone or with HCV is more likely in IVU. A large percentage of those with HBV are surface antibody negative. Many women show evidence of liver disease via elevated transaminase levels. Implications include: HIV testing of those with evidence of HBV and/or HCV; HBV vaccine for those without positive antibody and appropriate changes in prescribing practice in HIV-infected women with liver disease.
Publication Types:
Keywords:
- Acquired Immunodeficiency Syndrome
- Central Nervous System Viral Diseases
- Female
- HIV
- HIV Infections
- HIV Seropositivity
- HIV Seroprevalence
- Hepacivirus
- Hepatitis, Viral, Human
- Humans
- Incidence
- Substance Abuse, Intravenous
Other ID:
UI: 102209005
From Meeting Abstracts